Allakos Receives $17,949,545 New Financing

  • Feed Type
  • Date
    3/26/2015
  • Company Name
    Allakos
  • Mailing Address
    75 Shoreway Road San Carlos, CA 94070 USA
  • Company Description
    Allakos Inc. is a privately held, product-focused biotechnology company developing first-in-class antibody-based therapeutics to treat diseases in which dysregulation of the T-helper type 2 (Th2) immune response plays a key role in pathology, including allergic disease, inflammation and diseases characterized by excess production of inflammatory cells.
  • Website
    http://www.allakos.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,949,545
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy